No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs128543 |
chr21:44851265-44851266 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs146491317 |
chr21:44851275-44851276 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs141089066 |
chr21:44851277-44851278 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs568006308 |
chr21:44851280-44851281 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs376605311 |
chr21:44851289-44851290 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs143489718 |
chr21:44851290-44851291 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs184342738 |
chr21:44851296-44851297 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs368716520 |
chr21:44851297-44851298 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs571889884 |
chr21:44851325-44851326 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs541249802 |
chr21:44851371-44851372 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs539136809 |
chr21:44851418-44851419 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs146774608 |
chr21:44851462-44851463 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs140441950 |
chr21:44851463-44851464 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs537094566 |
chr21:44851467-44851468 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs559367619 |
chr21:44851473-44851474 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs573561173 |
chr21:44851489-44851490 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs150415401 |
chr21:44851511-44851512 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs559094972 |
chr21:44851551-44851552 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs145235519 |
chr21:44851554-44851555 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs532896437 |
chr21:44851572-44851573 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs374553587 |
chr21:44851582-44851583 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs568105331 |
chr21:44851584-44851585 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs563846866 |
chr21:44851586-44851587 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs112003559 |
chr21:44851647-44851648 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs188301877 |
chr21:44851675-44851676 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs542967102 |
chr21:44851688-44851689 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs561281545 |
chr21:44851730-44851731 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs528765560 |
chr21:44851758-44851759 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs551313103 |
chr21:44851780-44851781 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs181119989 |
chr21:44851788-44851789 |
Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs571851606 |
chr21:44851851-44851852 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs115129435 |
chr21:44851855-44851856 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs550894666 |
chr21:44851865-44851866 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs115589885 |
chr21:44851877-44851878 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs9982722 |
chr21:44851906-44851907 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs149173734 |
chr21:44851921-44851922 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs146698963 |
chr21:44851922-44851923 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs566947735 |
chr21:44851927-44851928 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs73382120 |
chr21:44851938-44851939 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs73906552 |
chr21:44851967-44851968 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs577406974 |
chr21:44851977-44851978 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs545236052 |
chr21:44851978-44851979 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs569595193 |
chr21:44851994-44851995 |
Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs556880307 |
chr21:44852064-44852065 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs185762955 |
chr21:44852099-44852100 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs542775616 |
chr21:44852106-44852107 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs561244420 |
chr21:44852159-44852160 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs190536556 |
chr21:44852187-44852188 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs540916471 |
chr21:44852195-44852196 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs181658022 |
chr21:44852206-44852207 |
Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|